FDA Import Refusal SCS-3990965-4/21/1 — Auro Pharma Inc.
The FDA refused shipment SCS-3990965-4/21/1 from Auro Pharma Inc. (Canada) on May 28, 2024. The refused product falls under Drugs and Biologics — CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 28, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61FCA55 CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
- Charges
- 75